Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Estimating the Long-Term Treatment Benefits of Sacubitril-Valsartan.

× No keyword cloud information.

31 in total

Review 1. Neprilysin Inhibition as a PARADIGM Shift in Heart Failure Therapy.

Authors: Ruth Hsiao; Barry Greenberg
Journal: Curr Heart Fail Rep Date: 2016-08

2. The Mechanism of Action of LCZ696.

Authors: Juan Tamargo Menendez
Journal: Card Fail Rev Date: 2016-05

3. Screening echocardiograms in a senior focused value based primary care improves systolic heart failure detection and clinical management.

Authors: Reyan Ghany; Leonardo Tamariz; Gordon Chen; Alina Ghany; Emancia Forbes; Thiago Tajiri; Ana Palacio
Journal: Cardiovasc Diagn Ther Date: 2017-06

Review 4. Role of circulating factors in cardiac aging.

Authors: Antonio Cannatà; Gabriella Marcon; Giovanni Cimmino; Luca Camparini; Giulio Ciucci; Gianfranco Sinagra; Francesco S Loffredo
Journal: J Thorac Dis Date: 2017-03 Impact factor: 2.895

Review 5. Angiotensin-Neprilysin Inhibition as a Paradigm for All?

Authors: Muthiah Vaduganathan; Akshay S Desai
Journal: Curr Cardiol Rep Date: 2016-11 Impact factor: 2.931

Review 6. Redefining the role of biomarkers in heart failure trials: expert consensus document.

Authors: Frank Kramer; Hani N Sabbah; James J Januzzi; Faiez Zannad; J Peter van Tintelen; Erik B Schelbert; Raymond J Kim; Hendrik Milting; Richardus Vonk; Brien Neudeck; Richard Clark; Klaus Witte; Wilfried Dinh; Burkert Pieske; Javed Butler; Mihai Gheorghiade
Journal: Heart Fail Rev Date: 2017-05 Impact factor: 4.214

Review 7. Sacubitril/Valsartan: A Review in Chronic Heart Failure with Reduced Ejection Fraction.

Authors: Paul L McCormack
Journal: Drugs Date: 2016-03 Impact factor: 9.546

Review 8. Sacubitril/Valsartan: From Clinical Trials to Real-world Experience.

Authors: Joanna M Joly; Akshay S Desai
Journal: Curr Treat Options Cardiovasc Med Date: 2018-04-23

9. Sacubitril/Valsartan (LCZ696): A Novel Treatment for Heart Failure and its Estimated Cost Effectiveness, Budget Impact, and Disease Burden Reduction in Germany.

Authors: Afschin Gandjour; Dennis A Ostwald
Journal: Pharmacoeconomics Date: 2018-10 Impact factor: 4.981

10. Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial.

Authors: Pratyaksh K Srivastava; Brian L Claggett; Scott D Solomon; John J V McMurray; Milton Packer; Michael R Zile; Akshay S Desai; Jean L Rouleau; Karl Swedberg; Gregg C Fonarow
Journal: JAMA Cardiol Date: 2018-12-01 Impact factor: 14.676